EVOKE

Serial Number 99203362
681

Registration Progress

Application Filed
May 27, 2025
Under Examination
Approved for Publication
Published for Opposition
Dec 30, 2025
Registered

Trademark Image

EVOKE

Basic Information

Serial Number
99203362
Filing Date
May 27, 2025
Published for Opposition
December 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Dec 8, 2025
Application
Pending
Classes
005

Rights Holder

Bioxcellerator LLC

16
Address
4900 N. Scottsdale Rd., Suite 3700
Scottsdale, AZ 85251

Ownership History

Bioxcellerator LLC

Original Applicant
16
Scottsdale, AZ

Legal Representation

Attorney
Perry Gattegno

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Dec 24, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 2, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 2, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 2, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 2, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 24, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 27, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 27, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biologics in the nature of pharmaceutical preparations for the treatment of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine being orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for the treatment and prevention of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine in the nature of orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for exosome treatments for medical purposes; Pharmaceutical preparations for treating chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes for the purpose of accelerating healing and improvement of personal health and wellness; Biologics in the nature of cells for the treatment of chronic conditions being orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and extracellular vesicles; Biological preparations for the treatment of chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and extracellular vesicles for the purpose of accelerating healing and improvement of personal health and wellness

Classification

International Classes
005